Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Net Margin (2019 - 2023)

Benitec Biopharma (BNTC) has disclosed Net Margin for 5 consecutive years, with 65114.29% as the latest value for Q2 2023.

  • Quarterly Net Margin changed N/A to 65114.29% in Q2 2023 from the year-ago period, while the trailing twelve-month figure was 317257.14% through Mar 2024, down 28886891.0% year-over-year, with the annual reading at 26082.67% for FY2023, 158130.0% down from the prior year.
  • Net Margin hit 65114.29% in Q2 2023 for Benitec Biopharma, down from 8051.85% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 8220.0% in Q2 2020 to a low of 379500.0% in Q1 2021.
  • Historically, Net Margin has averaged 80666.78% across 5 years, with a median of 8051.85% in 2023.
  • Biggest five-year swings in Net Margin: plummeted -37201786bps in 2021 and later skyrocketed 37227083bps in 2022.
  • Year by year, Net Margin stood at 2719.48% in 2019, then tumbled by -11891bps to 326100.0% in 2020, then skyrocketed by 94bps to 19384.0% in 2021, then tumbled by -107bps to 40135.71% in 2022, then crashed by -62bps to 65114.29% in 2023.
  • Business Quant data shows Net Margin for BNTC at 65114.29% in Q2 2023, 8051.85% in Q1 2023, and 40135.71% in Q4 2022.